Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Shares of Exelixis (NASDAQ:EXEL) moved higher in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share rose 48.00% year over year to $0.37, which beat the estimate of $0.07.
Revenue of $385,177,000 higher by 48.44% from the same period last year, which beat the estimate of $298,160,000.
Looking Ahead
Earnings guidance hasn't been issued by the company for now.
Exelixis hasn't issued any revenue guidance for the time being.
Details Of The Call
Date: Aug 05, 2021
Time: 05:00 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/f2ewr8h2
Technicals
Company's 52-week high was at $27.35
Company's 52-week low was at $16.19
Price action over last quarter: down 28.51%
Company Overview
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule cabozantinib is indicated for the treatment of patients with metastatic medullary thyroid cancer (as Cometriq) and advanced renal cell carcinoma, or kidney cancer, and hepatocellular carcinoma, or liver cancer (as Cabometyx). Exelixis and partner Roche have also brought Cotellic to market for the treatment of melanoma.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!